CLINICAL ROLE -
Warda Nawaz, PharmD, is a medical writer based in Rancho Cordova, California.
Once-Daily Oral Pill for Plaque Psoriasis Shows Promise
Deuvacracitinib (Sotyktu), which the FDA approved in September 2022, is a first-of-its-class tyrosine kinase 2 inhibitor and a member of the Janus kinase family.
Read More